# Preemptive Strike With Bortezomib in Multiple Myeloma Patients

> **NCT00657553** · PHASE3 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 10 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Bortezomib

## Key facts

- **NCT ID:** NCT00657553
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Due to poor accrual
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657553, "Preemptive Strike With Bortezomib in Multiple Myeloma Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00657553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*